Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.46 |
| ▸ | LPL | P06858 | 4/20 | 0.46 |
| ▸ | ABCG2 | Q9UNQ0 | 11/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.39 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31642621 | 0.97 | LIPG (0.50) | LIPGLPLABCG2ABCB1PDGFRB | |
| SCHEMBL31643042 | 0.93 | LIPG (0.46) | LIPGLPLABCG2ABCB1PDGFRB | |
| SCHEMBL23384077 | 0.87 | LIPG (0.60) | LIPGLPLABCG2ABCB1ABCC1 | |
| SCHEMBL31642888 | 0.87 | LIPG (0.55) | LIPGLPLPDGFRBKDRDGAT1 | |
| SCHEMBL27296159 | 0.86 | LIPG (0.51) | LIPGLPLPDGFRBKDRDGAT1 | |
| SCHEMBL31463120 | 0.86 | LIPG (0.63) | LIPGLPLABCG2ABCB1ABCC1 | |
| SCHEMBL31642580 | 0.86 | LIPG (0.54) | LIPGLPLPDGFRBKDRDGAT1 | |
| SCHEMBL31463142 | 0.85 | LIPG (0.42) | LIPGLPLABCG2ABCB1 | |
| SCHEMBL23383914 | 0.85 | LIPG (0.48) | LIPGLPLABCG2ABCB1ABCC1 | |
| SCHEMBL21507693 | 0.85 | LIPG (0.64) | LIPGLPLPDGFRBKDRDGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025135764-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2025-06-26 | — | — | WO | disclosed |